The ATS Keynote Series continues Monday with discussions about lung cancer detection and prevention, and the evolution of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The series showcases major discoveries in pulmonary, critical care, and sleep medicine. The lectures will be given concurrently from 8 to 8:45 a.m.
Avrum Spira, MD, MSc
Lung Cancer Detection and Prevention in the Precision Medicine Era
Moscone Center, Room 134 (North Building, Lower Level)
Avrum Spira, MD, MSc, chief of the Division of Computational Biomedicine, and professor of medicine, pathology, laboratory medicine, and bioinformatis, Boston University School of Medicine; director of the translational bioinformatics program, Clinical and Translational
Science Institute, Boston University,
Massachusetts
Nick H. Kim, MD
Pulmonary Hypertension: Evolution of PAH and CTEPH
Moscone Center, Room 135 (North Building, Lower Level)
Nick H. Kim, MD, clinical professor of medicine, director of pulmonary vascular medicine, and director of the pulmonary and critical care medicine fellowship at the University of California, San Diego School of Medicine; clinical service chief of Thornton PCCM, La Jolla, California
Lung Cancer Detection and Prevention in the Precision Medicine Era (K3) is supported by an educational grant from AstraZeneca LP.
Pulmonary Hypertension: Evolution of PAH and CTEPH (K4) is supported by educational grants from Actelion Pharmaceuticals US, Inc., Gilead Sciences, Inc., and United Therapeutics Corporation.